Safety and efficacy of outpatient follow-up for referred patients with undiagnosed fever: A retrospective cohort study.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
entrez:
1
2
2020
pubmed:
1
2
2020
medline:
14
2
2020
Statut:
ppublish
Résumé
Fever is one of the most common symptoms seen in patients. The work-up and follow-up of fever in an outpatient-only setting is a reasonable option for stable patients referred for unexplained fever; however, the safety and efficacy of outpatient follow-up for those patients remain unclear. We conducted this study to evaluate the safety and efficacy of outpatient follow-up for referred patients with unexplained fever.This study was a retrospective cohort study. We included patients referred to the outpatient department of the diagnostic medicine of our university hospital for unexplained fever between October 2016 and September 2017. Exclusion criteria were recurrent fever or admission for fever evaluation prior to referral. Main outcomes of interest were the rate of admission without diagnosis, rate of remission of fever, and the total duration of fever in undiagnosed patients.Among 84 patients included in this study, 17 (20%) were diagnosed during outpatient follow-up, 6 (7%) were admitted due to worsened condition, 5 (6%) were lost to follow-up, and 56 (67%) were followed up as outpatients without a diagnosis. Among the 56 undiagnosed patients, fever resolved in 53 during outpatient follow-up with or without treatment (95%). The total duration of resolved fever in undiagnosed patients was within 8 weeks.Follow-up of patients referred for unexplained fever in an outpatient setting is safe and effective.
Identifiants
pubmed: 32000362
doi: 10.1097/MD.0000000000018532
pii: 00005792-202001310-00009
pmc: PMC7004780
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e18532Références
BMC Infect Dis. 2019 Feb 27;19(1):198
pubmed: 30813923
Medicine (Baltimore). 2018 Oct;97(43):e12909
pubmed: 30412093
Int J Infect Dis. 2008 Jan;12(1):71-9
pubmed: 17629532
Clin Med (Lond). 2018 Mar;18(2):170-174
pubmed: 29626024
BMJ. 2010;341:C5470
pubmed: 22312655
Medicine (Baltimore). 2018 Jun;97(24):e10986
pubmed: 29901588
Medicine (Baltimore). 1993 May;72(3):184-96
pubmed: 8502169
Arch Intern Med. 2003 May 12;163(9):1033-41
pubmed: 12742800
Medicine (Baltimore). 2007 Jan;86(1):26-38
pubmed: 17220753
Infection. 2006 Apr;34(2):75-80
pubmed: 16703296
Arch Intern Med. 2003 Mar 10;163(5):545-51
pubmed: 12622601
Infection. 2006 Apr;34(2):87-90
pubmed: 16703298
Caspian J Intern Med. 2014 Winter;5(1):35-9
pubmed: 24490012
Acta Clin Belg. 2014 Jan-Feb;69(1):12-6
pubmed: 24635393
Medicine (Baltimore). 2018 Jun;97(25):e11241
pubmed: 29924054
QJM. 2017 Dec 1;110(12):793-801
pubmed: 29036369
Scand J Infect Dis. 2006;38(8):632-8
pubmed: 16857607
J Egypt Soc Parasitol. 2011 Aug;41(2):379-86
pubmed: 21980776
Int J Infect Dis. 2017 Sep;62:10-17
pubmed: 28652213